Sun Pharmaceutical Q3FY21 net profit at Rs. 1852.48 Cr
News

Sun Pharmaceutical Q3FY21 net profit at Rs. 1852.48 Cr

The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.

  • By IPP Bureau | February 01, 2021

Sun Pharmaceutical Industries has reported total income of Rs.9151.73 crores during the period ended December 31, 2020 as compared to Rs.8808.91 crores during the period ended September 30, 2020.

 

The company has posted net profit of Rs.1852.48 crores for the period ended December 31, 2020 as against net profit of Rs.1812.79 crores for the period ended September 30, 2020.

 

The company has reported EPS of Rs.7.72 for the period ended December 31, 2020 as compared to Rs.7.56 for the period ended September 30, 2020.

 

Sun Pharmaceutical Industries has reported total income of Rs.9151.73 crores during the period ended December 31, 2020 as compared to Rs.8274.73 crores during the period ended December 31, 2019.

 

The company has posted net profit of Rs.1852.48 crores for the period ended December 31, 2020 as against net profit of Rs.913.52 crores for the period ended December 31, 2019.

 

Sun Pharmaceutical Industries has reported EPS of Rs.7.72 for the period ended December 31, 2020 as compared to Rs.3.81 for the period ended December 31, 2019.

 

The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020 as compared to Rs.25186.31 crores during the 9 months period ended December 31, 2019.

 

Sun Pharmaceutical Industries has posted net profit of Rs.2009.67 crores for the 9 months period ended December 31, 2020 as against net profit of Rs.3365.09 crores for the 9 months period ended December 31, 2019.

 

The company has reported EPS of Rs.8.38 for the 9 months period ended December 31, 2020 as compared to Rs.14.03 for the 9 months period ended December 31, 2019.

Upcoming E-conference

Other Related stories

Startup

Digitization